Skip Navigation LinksHome > March/April 2012 - Volume 4 - Issue 2 > Infliximab in the Treatment of Severe Recalcitrant Hidradeni...
Journal of the Dermatology Nurses' Association:
doi: 10.1097/JDN.0b013e31824ab96f
Case Report

Infliximab in the Treatment of Severe Recalcitrant Hidradenitis Suppurativa and Concomitant Rheumatoid Arthritis: A Case Study

Ward, Muriel

Collapse Box


ABSTRACT: A 52-year-old man presents to a private dermatology clinic with a history of severe recalcitrant hidradenitis suppurativa (HS) and concomitant rheumatoid arthritis. The patient is an active duty master sergeant in the U.S. Army and has just relocated for a permanent change of station to active drilling reservist status. He is motivated to continue managing his HS with infliximab, and he wishes to explore insurance coverage. Although not indicated for treating HS, infliximab may be a viable option for severe recalcitrant HS. The following case study presents the history, assessment and plan, treatment, evaluation, and discussion highlighting important points regarding the use of a biological agent in severe recalcitrant HS and concomitant rheumatoid arthritis.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.